Washington University in St. Louis researchers will adapt their COVID-19-detecting breathalyzer to one that can also screen for common seasonal viruses with a two-year $3.6 million grant from Flu Lab.
Millions received the COVID-19 vaccine, which was the first widely used immunization to use mRNA technology. Washington University researchers hope they can use the same method to make an mRNA flu shot.
Millions received the COVID-19 vaccine, which was the first widely used immunization to use mRNA technology. Washington University researchers hope they can use the same method to make an mRNA flu shot.
The way out : Trials in St. Louis helped build a 95% effective vaccine
Work persists at SLU, Washington University as first batches roll out
Scott Marion, smarion@edwpub.net
FacebookTwitterEmail
Dr. Sharon Frey, clinical director of St. Louis University’s Center for Vaccine Development, serves as the principal investigator of the COVID-19 vaccine trials at SLU.St. Louis University photo
ST. LOUIS With the first batches of the COVID-19 vaccine rolling out this week across the United States, several researchers from the St. Louis area are part of the effort to end the pandemic.
Researchers at the St. Louis University Center for Vaccine Development and Washington University School of Medicine are participating in COVID-19 vaccine trials, with each school participating in different trials.